Your browser doesn't support javascript.
loading
The 5-HT2A/2C inverse agonist nelotanserin alleviates L-DOPA-induced dyskinesia in the MPTP-lesioned marmoset.
Kwan, Cynthia; Frouni, Imane; Bédard, Dominique; Hamadjida, Adjia; Nuara, Stephen G; Gourdon, Jim C; Huot, Philippe.
Affiliation
  • Kwan C; Neurodegenerative Disease Group, Montreal Neurological Institute-Hospital (The Neuro), Montreal, Quebec, Canada.
  • Frouni I; Neurodegenerative Disease Group, Montreal Neurological Institute-Hospital (The Neuro), Montreal, Quebec, Canada.
  • Bédard D; Département de Pharmacologie et Physiologie, Université de Montréal, Montreal, Quebec, Canada.
  • Hamadjida A; Neurodegenerative Disease Group, Montreal Neurological Institute-Hospital (The Neuro), Montreal, Quebec, Canada.
  • Nuara SG; Neurodegenerative Disease Group, Montreal Neurological Institute-Hospital (The Neuro), Montreal, Quebec, Canada.
  • Gourdon JC; Comparative Medicine & Animal Resource Centre, McGill University, Montreal, Quebec, Canada.
  • Huot P; Comparative Medicine & Animal Resource Centre, McGill University, Montreal, Quebec, Canada.
Eur J Neurosci ; 59(6): 1169-1176, 2024 Mar.
Article in En | MEDLINE | ID: mdl-37515363

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylurea Compounds / Pyrazoles / Parkinsonian Disorders / Dyskinesia, Drug-Induced Type of study: Clinical_trials Limits: Animals Language: En Journal: Eur J Neurosci Journal subject: NEUROLOGIA Year: 2024 Type: Article Affiliation country: Canada

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylurea Compounds / Pyrazoles / Parkinsonian Disorders / Dyskinesia, Drug-Induced Type of study: Clinical_trials Limits: Animals Language: En Journal: Eur J Neurosci Journal subject: NEUROLOGIA Year: 2024 Type: Article Affiliation country: Canada